GLP-1 medicines for weight loss are increasingly popular in the U.S., prompting employers to consider coverage for employees. While not as common yet globally, GLP-1s spark a broader discussion around using data and analytics to identify health risks and address obesity as a disease.

Accede al recurso completo

Fuente: Aon